Now showing items 1-1 of 1

    Issue DateTitleAuthor(s)
    7 September 2022Dupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baseline.  Bourdin, A; Virchow, JC; Papi, A; et al.